MTOR and urinary bladder cancer: Abnormal expression of mTOR has been described in several types of cancers, including kidney renal clear cell carcinoma (KIRC), bladder cancer (BLCA), primary liver cancer, esophageal carcinoma, and colorectal adenocarcinoma [21–25].